Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics

Roberto Minutolo, Francesco Locatelli, Maurizio Gallieni, Renzo Bonofiglio, Giorgio Fuiano, Lamberto Oldrizzi, Giuseppe Conte, Luca De Nicola, Filippo Mangione, Pasquale Esposito, Antonio Dal Canton

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background. Knowledge on anaemia management in nondialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods. We prospectively evaluated anaemia management in two visits, performed 6 months apart, in 755 prevalent ND-CKD stage 3b-5 patients followed in 19 nephrology clinics from ≥6 months. Anaemia was defined as severe (Hb 2; male gender, diabetes and prior cardiovascular disease were 57.2, 30.1 and 30.1%, respectively. Prevalence of severe and mild anaemia was 18.0 and 44.0% at baseline and remained unchanged at Month 6 (19.3 and 43.2%). ID was prevalent at both visits (60.1 and 60.9%). Clinical inertia to ESA was similar at baseline and at Month 6 (39.6 and 34.2%, respectively, P = 0.487) and it was less frequent than clinical inertia to iron therapy (75.7 and 72.0%, respectively). Conclusions. This study shows that anaemia prevalence is unexpectedly high in the setting of tertiary nephrology care. This was due to a persistent clinical inertia in the anaemia management, remarkable for iron supplementation and less critical, but still significant, for ESA treatment.

Original languageEnglish
Pages (from-to)3035-3045
Number of pages11
JournalNephrology Dialysis Transplantation
Volume28
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Chronic Renal Insufficiency
Multicenter Studies
Anemia
Prospective Studies
Kidney
Nephrology
Iron
Tertiary Healthcare
Cardiovascular Diseases
Therapeutics

Keywords

  • Anaemia
  • Chronic kidney disease
  • ESA
  • Iron deficiency
  • Iron therapy

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Minutolo, R., Locatelli, F., Gallieni, M., Bonofiglio, R., Fuiano, G., Oldrizzi, L., ... Dal Canton, A. (2013). Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics. Nephrology Dialysis Transplantation, 28(12), 3035-3045. https://doi.org/10.1093/ndt/gft338

Anaemia management in non-dialysis chronic kidney disease (CKD) patients : A multicentre prospective study in renal clinics. / Minutolo, Roberto; Locatelli, Francesco; Gallieni, Maurizio; Bonofiglio, Renzo; Fuiano, Giorgio; Oldrizzi, Lamberto; Conte, Giuseppe; De Nicola, Luca; Mangione, Filippo; Esposito, Pasquale; Dal Canton, Antonio.

In: Nephrology Dialysis Transplantation, Vol. 28, No. 12, 12.2013, p. 3035-3045.

Research output: Contribution to journalArticle

Minutolo, R, Locatelli, F, Gallieni, M, Bonofiglio, R, Fuiano, G, Oldrizzi, L, Conte, G, De Nicola, L, Mangione, F, Esposito, P & Dal Canton, A 2013, 'Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics', Nephrology Dialysis Transplantation, vol. 28, no. 12, pp. 3035-3045. https://doi.org/10.1093/ndt/gft338
Minutolo, Roberto ; Locatelli, Francesco ; Gallieni, Maurizio ; Bonofiglio, Renzo ; Fuiano, Giorgio ; Oldrizzi, Lamberto ; Conte, Giuseppe ; De Nicola, Luca ; Mangione, Filippo ; Esposito, Pasquale ; Dal Canton, Antonio. / Anaemia management in non-dialysis chronic kidney disease (CKD) patients : A multicentre prospective study in renal clinics. In: Nephrology Dialysis Transplantation. 2013 ; Vol. 28, No. 12. pp. 3035-3045.
@article{a17a6c7d962d4c20844f80395ef592ce,
title = "Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics",
abstract = "Background. Knowledge on anaemia management in nondialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods. We prospectively evaluated anaemia management in two visits, performed 6 months apart, in 755 prevalent ND-CKD stage 3b-5 patients followed in 19 nephrology clinics from ≥6 months. Anaemia was defined as severe (Hb 2; male gender, diabetes and prior cardiovascular disease were 57.2, 30.1 and 30.1{\%}, respectively. Prevalence of severe and mild anaemia was 18.0 and 44.0{\%} at baseline and remained unchanged at Month 6 (19.3 and 43.2{\%}). ID was prevalent at both visits (60.1 and 60.9{\%}). Clinical inertia to ESA was similar at baseline and at Month 6 (39.6 and 34.2{\%}, respectively, P = 0.487) and it was less frequent than clinical inertia to iron therapy (75.7 and 72.0{\%}, respectively). Conclusions. This study shows that anaemia prevalence is unexpectedly high in the setting of tertiary nephrology care. This was due to a persistent clinical inertia in the anaemia management, remarkable for iron supplementation and less critical, but still significant, for ESA treatment.",
keywords = "Anaemia, Chronic kidney disease, ESA, Iron deficiency, Iron therapy",
author = "Roberto Minutolo and Francesco Locatelli and Maurizio Gallieni and Renzo Bonofiglio and Giorgio Fuiano and Lamberto Oldrizzi and Giuseppe Conte and {De Nicola}, Luca and Filippo Mangione and Pasquale Esposito and {Dal Canton}, Antonio",
year = "2013",
month = "12",
doi = "10.1093/ndt/gft338",
language = "English",
volume = "28",
pages = "3035--3045",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Anaemia management in non-dialysis chronic kidney disease (CKD) patients

T2 - A multicentre prospective study in renal clinics

AU - Minutolo, Roberto

AU - Locatelli, Francesco

AU - Gallieni, Maurizio

AU - Bonofiglio, Renzo

AU - Fuiano, Giorgio

AU - Oldrizzi, Lamberto

AU - Conte, Giuseppe

AU - De Nicola, Luca

AU - Mangione, Filippo

AU - Esposito, Pasquale

AU - Dal Canton, Antonio

PY - 2013/12

Y1 - 2013/12

N2 - Background. Knowledge on anaemia management in nondialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods. We prospectively evaluated anaemia management in two visits, performed 6 months apart, in 755 prevalent ND-CKD stage 3b-5 patients followed in 19 nephrology clinics from ≥6 months. Anaemia was defined as severe (Hb 2; male gender, diabetes and prior cardiovascular disease were 57.2, 30.1 and 30.1%, respectively. Prevalence of severe and mild anaemia was 18.0 and 44.0% at baseline and remained unchanged at Month 6 (19.3 and 43.2%). ID was prevalent at both visits (60.1 and 60.9%). Clinical inertia to ESA was similar at baseline and at Month 6 (39.6 and 34.2%, respectively, P = 0.487) and it was less frequent than clinical inertia to iron therapy (75.7 and 72.0%, respectively). Conclusions. This study shows that anaemia prevalence is unexpectedly high in the setting of tertiary nephrology care. This was due to a persistent clinical inertia in the anaemia management, remarkable for iron supplementation and less critical, but still significant, for ESA treatment.

AB - Background. Knowledge on anaemia management in nondialysis chronic kidney disease (ND-CKD) patients regularly followed in renal clinics is scarce although being essential to identifying areas of therapeutic improvement. Methods. We prospectively evaluated anaemia management in two visits, performed 6 months apart, in 755 prevalent ND-CKD stage 3b-5 patients followed in 19 nephrology clinics from ≥6 months. Anaemia was defined as severe (Hb 2; male gender, diabetes and prior cardiovascular disease were 57.2, 30.1 and 30.1%, respectively. Prevalence of severe and mild anaemia was 18.0 and 44.0% at baseline and remained unchanged at Month 6 (19.3 and 43.2%). ID was prevalent at both visits (60.1 and 60.9%). Clinical inertia to ESA was similar at baseline and at Month 6 (39.6 and 34.2%, respectively, P = 0.487) and it was less frequent than clinical inertia to iron therapy (75.7 and 72.0%, respectively). Conclusions. This study shows that anaemia prevalence is unexpectedly high in the setting of tertiary nephrology care. This was due to a persistent clinical inertia in the anaemia management, remarkable for iron supplementation and less critical, but still significant, for ESA treatment.

KW - Anaemia

KW - Chronic kidney disease

KW - ESA

KW - Iron deficiency

KW - Iron therapy

UR - http://www.scopus.com/inward/record.url?scp=84890059647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890059647&partnerID=8YFLogxK

U2 - 10.1093/ndt/gft338

DO - 10.1093/ndt/gft338

M3 - Article

C2 - 24145459

AN - SCOPUS:84890059647

VL - 28

SP - 3035

EP - 3045

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 12

ER -